Risk stratification for sudden cardiac death: Current status and challenges for the future

European Heart Journal

Volumn 35, Issue 25, 2014, Pages 1642-1651

  Wellens, Hein J J ^a   Schwartz, Peter J ^b   Lindemans, Fred W ^c   Buxton, Alfred E ^d   Goldberger, Jeffrey J ^e   Hohnloser, Stefan H ^f   Huikuri, Heikki V ^g   Kääb, Stefan ^h,i   La Rovere, Maria Teresa ^j   Malik, Marek ^k   Myerburg, Robert J ^l   Simoons, Maarten L ^m   Swedberg, Karl ⁿ   Tijssen, Jan ^o   Voors, Adriaan A ^p   Wilde, Arthur A ^q,r  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f GOETHE UNIVERSITY   (Germany)

^g MEDICAL RESEARCH CENTER OULU   (Finland)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^j IRCCS   (Italy)

^k IMPERIAL COLLEGE LONDON   (United Kingdom)

^l UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^m ERASMUS MEDICAL CENTER   (Netherlands)

ⁿ UNIVERSITY OF GOTHENBURG   (Sweden)

^o UNIVERSITY OF AMSTERDAM   (Netherlands)

^p UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^q ACADEMIC MEDICAL CENTER   (Netherlands)

^r KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

more..

Author keywords

Autonomic nervous system; Cardiac function; Electrical instability; Genetics; Risk stratification; Sudden cardiac death

Indexed keywords

ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIAC PATIENT; CARDIOVASCULAR RISK; DISEASE REGISTRY; DISEASE SEVERITY; ECG ABNORMALITY; ELECTROCARDIOGRAM; GENETIC SCREENING; GENETICS; HEART ARRHYTHMIA; HEART DISEASE; HEART FUNCTION; HUMAN; MEDICAL HISTORY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK MANAGEMENT; SUDDEN CARDIAC DEATH; AGED; ARRHYTHMIAS, CARDIAC; AUTONOMIC NERVOUS SYSTEM DISEASES; COMPLICATION; DEATH, SUDDEN, CARDIAC; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; FORECASTING; HEART FAILURE; HEART FUNCTION TEST; HEART LEFT VENTRICLE FUNCTION; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; TRENDS;

BIOLOGICAL MARKER;

AGED; ARRHYTHMIAS, CARDIAC; AUTONOMIC NERVOUS SYSTEM DISEASES; BIOLOGICAL MARKERS; DEATH, SUDDEN, CARDIAC; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; FORECASTING; GENETIC TESTING; HEART FAILURE; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; VENTRICULAR FUNCTION, LEFT;

EID: 84903999617     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu176     Document Type: Article

References (121)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela MB, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nicol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein JL, Turan TN, Virani SS, Wong ND, Woo D, Turner MB. Executive Summary: Heart Disease and Stroke Statistics-2013 Update. A report from the American Heart Association. Circulation 2013;127:143-152.
2. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe: epidemiological update. Eur Heart J 2013;34:3028-3034.
3. Nichols M, Townsend N, Scarborough P, Rayner M. Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009. Eur Heart J 2013;34:3017-3027.
4. Danchin N, Puymirat E, Simon T. The (possibly) deceptive figures of decreased coronary heart disease mortality in Europe. Eur Heart J 2013;34:3014-3016.
5. Pagidipati NJ, Gaziano TA. Estimating deaths from cardiovascular disease. A review of global methodologies of mortality measurement. Circulation 2013;127:749-756.
6. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: structure, function, and time dependence of risk. Circulation 1992;85(Suppl. 1):2-10.
7. De Vreede-Swagemakers J, Gorgels A, Dubois-Arbouw W, Daemen M, van Ree J, Houben L, Wellens HJJ. Out-of-Hospital cardiac arrest in the 1990's. A population based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997;30:1500-1505.
8. Stecker EC, Vickers C, Waltz J, Sosatearu C, John BT, Mariani R, McAnulty JH, Gunson K, Jui J, Chugh SS. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon sudden unexpected death study. J Am Coll Cardiol 2006;47:1161-1166.
9. Lloyd-Jones DM, Wilson PW, Larson MG. Framingham risk score and prediction of life time risk for coronary artery disease. Am J Cardiol 2004;94:20-24.
10. Laslett LJ, Alagona P, Clark III BA, Drozda JP, Saldivar F, Wilson SR, Poe C, Hart M. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy and policy issues: a report from the American College of Cardiology. J Am Coll Cardiol 2012;60(Suppl. S):1-49.
11. Menotti A, Lanti M, Kromhout D, Blackburn H, Jacobs D, Nissinen A, Dontas A, Kafatos A, Nedelikovic S, Adachi H. Homogeneity in the relationship of serum cholesterol to coronary deaths across different cultures: 40-year follow-up of the seven countries study. Eur J Cardiovasc Prev Rehabil 2008;15:719-725.
12. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012;33: 1635-1701.
13. Allan GM, Nouri F, Korownyk C, Kolber MR, Vandermeer B, McCormack J. Agreement among cardiovascular disease risk calculators. Circulation 2013;127: 1948-1956.
14. Willis A, Davies M, Yates T, Khunti K. Primary prevention of cardiovascular disease using validated risk scores: a systematic review. J R Soc Med 2012;105:348-356.
15. Avery CL, Loehr LR, Baggett C, Chang PP, Kucharska-Newton AM, Matsushita K, Rosamund WD, Heiss G. The population burden of heart failure attributable to modifiable risk factors: the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol 2012;60:1640-1646.
16. Van Kimmenade RRJ, Januzzi Jr JL. Emerging biomarkers in heart failure. Clin Chem 2012;58:127-138.
17. Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation 2012;125:1043-1052.
18. Soliman EZ, Prineas RJ, Case LD, Russell G, Rosamund W, Rea T, Sotoodehnia N, Post WS, Siscovick D, Psaty BM, Burke GL. Electrocardiographic and clinical predictors separating atherosclerotic sudden cardiac death from incident coronary heart disease. Heart 2011;97:1597-1601.
19. Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P. Heart rate profile during exercise as a predictor of sudden death. N Engl J Med 2005; 352:1951-1958.
20. Jouven X, Empana JP, Escolano S, Buyck JF, Tafflet M, Desnos M, Ducimetiere P. Relation of heart rate at rest and long-term (>20 years) death rate in initially healthy middle-aged men. Am J Cardiol 2009;103:279-283.
21. Jouven X, Schwartz PJ, Escolano S, Straczek C, Tafflet M, Desnos M, Empana JP, Ducimetiere P. Excessive heart rate increase during mild mental stress in preparation for exercise predicts sudden death in the general population. Eur Heart J 2009;30:1703-1710.
22. Greenland P, Daviglus ML, Dyer AR, Liu K, Huang C, Goldberger J, Stamler J. Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. Am J Epidemol 1999; 149:853-862.
23. Montanez A, Ruskin JN, Hebert PR, Lamas GA, Hennekens CH. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population. A review and qualitative overview of the prospective cohort studies. Arch Intern Med 2004;164:943-948.
24. Straus SMJM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, Deckers JW, Kingma JH, Sturkenboom MCJM, Stricker BHC, Witteman JCM. Prolonged QTcinterval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 2006;47:362-367.
25. Panikkath R, Reinier K, Uy-Evanado A, Teodorescu C, Hattenhauer J, Mariani R, Gunson K, Jui J, Chugh SS. Prolonged Tpeak-to-Tend interval on the resting ECG is associated with increased risk of sudden cardiac death. Circ ArrhythmElectrophysiol 2011;4:441-447.
26. Tikkanen JT, Anttonen O, Junttila MJ, Aro AL, Kerola T, Rissanen HA, Reunanen A, Huikuri HV. Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med 2009;361:2529-2537.
27. Aro AL, Anttonen O, Tikkanen JT, Junttila MJ, Kerola T, Rissanen H, Reunanen A, Huikuri HV. Intraventricular conduction delay in a standard 12-lead electrocardiogram as a predictor of mortality in general population. Circ Arrhythm Electrophysiol 2011;4:704-710.
28. Aro AL, Anttonen O, Kerola T, Tikkanen JT, Junttila MJ, Rissanen H, Reunanen A, Huikuri HV. Prevalence and prognostic significance of T-Wave inversions in right precordial leads of a 12-lead electrocardiogram in the middle-aged subjects. Circulation 2012;125:2572-2577.
29. Aro AL, Huikuri HV, Tikkanen JT, Junttila MJ, Rissanen HA, Reunanen A, Anttonen O. QRS-T angle as a predictor of sudden cardiac death in a middle-aged general population. Europace 2012;14:872-8712.
30. Bauer A, Barthel P, Schneider R, Ulm K, Müller A, Joeinig A, Stich R, Kiviniemi A, Hnatkova K, Huikuri H, Schömig A, Malik M, Schmidt G. Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J 2009;30:576-583.
31. Mäkikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, Schmidt G, Huikuri HV. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J 2005; 26:762-769.
32. Merchant FM, Ikeda T, Pedretti RF, Salerno-Uriarte JA, Chow T, Chan PS, Bartone C, Hohnloser SH, Cohen RJ, Armoundas AA. Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death. Heart Rhythm 2012;8:1256-1264.
33. Huikuri HV, Exner DV, Kavanagh KM, Aggarwal SG, Mitchell LB, Messier MD, Becker D, Sheldon RS, Bloch Thomsen PE, CARISMA and REFINE Investigators. Attenuated recovery of heart rate turbulence early after myocardial infarction identifies patients at high risk for fatal or near-fatal arrhythmic events. Heart Rhythm 2010;7:229-235.
34. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ, for the ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998;351:478-484.
35. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitkamp L, Vincent GM, Garson A Jr, Robinson JL, Benhorin J, Choi S. The long QT syndrome: prospective longitudinal study of 328 families. Circulation 1991;84: 1136-1144.
36. Brink PA, Crotti L, Corfield V, Goosen A, Durrheim G, Hedley P, Heradien M, Geldenhuys G, Vanoli E, Bacchini S, Spazzolini C, Lundquist AL, Roden DM, George AL Jr, Schwartz PJ. Phenotypic variability and unusual clinical severity of congenital long QT syndrome in a founder population. Circulation 2005;112: 2602-2610.
37. Kanda T. Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies. J Neurol Neurosurg Psychiatry 2013;84:208-212.
38. Fleischer J. Diabetic autonomic imbalance and glycemic variability. J Diabetes Sci Technol 2012;6:1207-1215.
39. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 1971;285:877-883.
40. Barthel P, Bauer A, Müller A, Junk N, Huster KM, Ulm K, Malik M, Schmidt G. Reflex and tonic autonomic markers for risk stratification in patients with type 2 diabetes surviving acute myocardial infarction. Diabetes Care 2011;34:1833-1837.
41. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 1991;68:1471-1481.
42. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976; 294:1165-1170.
43. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992;85(Suppl. I):I77-I91.
44. Vaseghi M, Ajijola OA, Mahajan A, Shivkumar K. Sympathetic innervation, denervation, and cardiac arrhythmias. In Zipes DP, Jalife J, eds. Cardiac electrophysiology. From Cell to Bedside, 6th ed. Philadelphia: Elsevier Saunders; 2014, pp. 409-417.
45. Malik M. (Ed). Clinical Guide to Cardiac Autonomic Tests. Dordrecht, The Netherlands: Kluwer Academic Publisher; 1998; ISBN: 978-90-481-5071-7.
46. La Rovere MT, Schwartz PJ. Baroreflex sensitivity. In Zipes DP, Jalife J, eds. Cardiac electrophysiology. From Cell to Bedside, 3rd ed. Philadelphia:WBSaunders Co.; 2000, pp. 771-781.
47. Barthel P, Bauer A, Muller A, Huster KM, Kanters JK, Paruchuri V, Yang X, Ulm K, Malik M, Schmidt G. Spontaneous baroreflex sensitivity: prospective validation trial of a novel technique in survivors of acute myocardial infarction. Heart Rhythm 2012;9:1288-1294.
48. Billman GE, Schwartz PJ, Stone HL. Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation 1982;66:874-880.
49. Schwartz PJ, Vanoli E, Stramba-Badiale M, De Ferrari GM, Billman GE, Foreman RD. Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988;78:969-979.
50. La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R, Bigger JT Jr, Camm AJ, Schwartz PJ, on behalf of the ATRAMI Investigators. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for lifethreatening arrhythmias. Implications for clinical trials. Circulation 2001;103: 2072-2077.
51. LaRovere MT, Pinna GD, Maestri R, Robbi E, Caporotondi A, Guazzotti G, Sleight P, Febo O. Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J Am Coll Cardiol 2009;53:193-199.
52. Bauer A, Malik M, Schmidt G, Barthel P, Bonnemeier H, Cygankiewicz I, Guzik P, Lombardi F, Müller A, Oto A, Schneider R, Watanabe M, Wichterle D, Zareba W. Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol 2008;52:1353-1365.
53. Bauer A, Kantelhardt JW, Barthel P, Schneider R, Mäkikallio T, Ulm K, Hnatkova K, Schömig A, Huikuri H, Bunde A, Malik M, Schmidt G. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet 2006;367:1674-1681.
54. Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 1999;341: 1351-1357.
55. Johnson NP, Goldberger JJ. Prognostic value of late heart rate recovery after treadmill exercise. Am J Cardiol 2012;110:45-49.
56. Pomeranz M, Macaulay RJB, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ, Benson M. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985;248:H151-H153.
57. Montano N, Gnecchi-Ruscone T, Porta A, Lombardi F, Pagani M, Malliani M. Power spectrum analysis of heart rate variability to assess the changes in sympatho-vagal balance during graded orthostatic tilt. Circulation 1994;90:1826-1831.
58. De Ferrari GM, Sanzo A, Bertoletti A, Specchia G, Vanoli E, Schwartz PJ. Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol 2007; 50:2285-2290.
59. Wichterle D, Simek J, LaRovere MT, Schwartz PJ, Camm AJ, Malik M. Prevalent lowfrequency oscillation of heart rate: novel predictor of mortality after myocardial infarction. Circulation 2004;110:1183-1190.
60. Stein PK, Pu Y. Heart rate variability, sleep and sleep disorders. Sleep Med Rev 2012; 16:47-66.
61. La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, Ferrari R, Franchini M, Gnemmi M, Opasich C, Riccardi PG, Traversi E, Cobelli F. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003;107:565-570.
62. Malik M. Autonomic tests to detect cardiac risk and their clinical practicality. J Cardiovasc Electrophysiol 2011;22:128-130.
63. Crotti L, Spazzolini C, Porretta AP, Dagradi F, Taravelli E, Petracci B, Vicentini A, Pedrazzini M, La Rovere MT, Vanoli E, Goosen A, Heradien M, George AL Jr, Brink PA, Schwartz PJ. Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. J Am Coll Cardiol 2012;60:2515-2524.
64. Falcone C, Buzzi MP, Klersy C, Schwartz PJ. Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease. Circulation 2005;112:1959-1964 (Erratum: 2005;112:e295).
65. Odemuyiwa O, Malik M, Farrell T, Bashir Y, Poloniecki J, Camm AJ. Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am J Cardiol 1991;68:434-439.
66. Berger RD, Kasper EK, Baughman KL, Marban E, Calkins H, Tomaselli GF. Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997;96:1557-1565.
67. Porta A, Tobaldini E, Gnecchi-Ruscone T, Montano N. RT variability unrelated to heart period and respiration progressively increases during graded head-up tilt. Am J Physiol 2010;298:H1406-H1414.
68. Zabel M, Acar B, Klingenheben T, Franz MR, Hohnloser SH, Malik M. Analysis of 12-lead T-wave morphology for risk stratification after myocardial infarction. Circulation 2000;102:1252-1257.
69. Bari V, Valencia JF, Vallverdú M, Girardengo G, Marchi A, Bassani T, Caminal P, Cerutti S, George AL Jr, Brink PA, Crotti L, Schwartz PJ, Porta A. Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. PLoS One 2014;9:e93808. doi: 10.1371/journal.pone.0093808.
70. Schwartz PJ, Vanoli E, Crotti L, Spazzolini C, Ferrandi C, Goosen A, Hedley P, Heradien M, Bacchini S, Turco A, La Rovere MT, Bartoli A, George AL Jr, Brink PA. Neural control of heart rate is an arrhythmia risk modifier in longQTsyndrome. J Am Coll Cardiol 2008;51:920-929.
71. Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, Dibbets-Schneider P, Stokkel MP, van der Wall EE, Schalij MJ, Bax JJ. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverterdefibrillator patients. J Am Coll Cardiol 2010;55:2769-2777.
72. Narayanan K, Reinier K, Uy-Evanado A, Teodorescu C, Chugh H, Marijon E, Gunson K, Jui J, Chugh SS. Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community. Circulation 2013;128:1733-1738.
73. Albert CM, Stevenson WG. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: too little and too late? Circulation 2013;128: 1721-1723.
74. Gorgels APM, Gijsbers C, de Vreede-Swagemakers J, Lousberg A, Wellens HJJ. Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J 2003;24:1204-1209.
75. Ross AM, Coyne KS, Moreyra E, Reiner JS, Greenhouse SW, Walker PL, Simoons ML, Draoui YC, Califf RM, Topol EJ, Van de Werf F, Lundergan CF. Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries trial. Circulation 1998;97:1549-1556.
76. Solomon SD, Wang D, Finn P, Skali H, Zornoff L, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pocock S, Pfeiffer MA. Effect of candesartan on causespecific mortality in heart failure patients. The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Program. Circulation 2004; 110:2180-2183.
77. Yap YG, Duong T, Bland JM, Malik M, Torp-Pedersen C, Kober L, Gallagher MM, Camm AJ. Optimising the dichotomy limit for left ventricular ejection fraction in selecting patients for defibrillator therapy after myocardial infarction. Heart 2007; 93:832-836.
78. Dagres N, Hindricks G. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?. Eur Heart J 2013;34:1964-1971.
79. Pouleur AC, Barkoudah E, Uno H, Skali H, Finn PV, Zelenkofske SL, Belenkov Y, Mareev V, Velazques EJ, Rouleau JL, Maggioni AP, Kober L, Califf RM, McMurray JJ, Pfeffer MA, Solomon SD. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation 2010;122:597-602.
80. Jackowski C, Schwendener N, Grabherr S, Persson A. Post-mortem cardiac 3-T magnetic resonance imaging visualization of sudden cardiac death? J Am Coll Cardiol 2013;62:617-629.
81. Uretsky BF, Thygesen K, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Packer M, Poole-Wilson PA, Ryden L. Acute coronary findings at autopsy in heart failure patients with sudden death. Results fromthe Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial. Circulation 2000;102:611-616.
82. MERIT-HF Study Group. Effectof metoprolol CR/XLin chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.
83. Adabag S, Smith LG, Anand IS, Berger AK, Luepker RV. Sudden cardiac death in heart failure patients with preserved ejection fraction. J Card Fail 2012;18:749-754.
84. Hamaguchi S, Kinugawa S, Sobirin MA, Goto D, Tsuchihashi-Makaya M, Yamada S, Yokoshiki H, Tsutsui H. Mode of death in patients with heart failure and reduced vs. preserved ejection fraction: report from the registry of hospitalized heart failure patients. Circ J 2012;76:1662-1669.
85. Chan MM, Lam CS. Howdo patients with heart failure with preserved ejection fraction die? Eur J Heart Fail 2013;15:604-613.
86. Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, Boehmer JP, Carlson MD, Frantz RP, McNulty SE, Rogers JG, Anderson J, Johnson GW, Walsh MN, Poole JE, Mark DB, Lee KL, Bardy GH. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation 2009;120:2170-2176.
87. Al-Khatib SM, Shaw LK, O'Connor C, Kong M, Califf RM. Incidence and predictors of sudden cardiac death in patients with diastolic heart failure. J Cardiovasc Electrophysiol 2007;18:1231-1235.
88. Zile MR, Gaasch WH, Anand IS, Haass M, Little WC, Miller AB, Lopez-Sendon J, Teerlink JR, White M, McMurray JJ, Komajda M, Mackelvie R, Ptaszynska A, Hetzel SJ, Massie BM, Carson PE. Mode of death in patients with heart failure and a preserved ejection fraction: results from the irbesartan in heart failure with preserved ejection fraction study (I-Preserve) trial. Circulation 2010;121:1393-1405.
89. Ikeda T, Yoshino H, Sugi K, Tanno K, Shimizu H, Watanabe J, Kasamaki Y, Yoshida A, Kato T. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac functionafter acute myocardial infarction: results of a collaborative cohort stud. J Am Coll Cardiol 2006;48:2268-2274.
90. Bauer A, Barthel P, Muller A, Ulm K, Huikuri H, Malik M, Schmidt G. Risk prediction by heart rate turbulence and deceleration capacity in postinfarction patients with preserved left ventricular function retrospective analysis of 4 independent trials. J Electrocardiol 2009;42:597-601.
91. Buxton A, Lee K, Hafley G, Pires LA, Fisher JD, Gold MR, Josephson ME, Lehmann MH, Prystowski EN. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease. Lessons from the MUSTT study. J Am Coll Cardiol 2007;50:1150-1157.
92. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton p, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006;113:1424-1433.
93. Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JG, Carson PE, Maggioni AP, Mann DL, Pitt B, Poole-Wilson PA, Levy WC. Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation 2007;116: 392-398.
94. van Veldhuisen DJ, Linssen GC, Jaarsma T, Van Gilst WH, Hoes AW, Tijssen JG, Paulus WJ, Voors AA, Hillege HL. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol 2013;61:1498-1506.
95. Scott PA, Barry J, Roberts PR, Morgan JM. Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis. Eur J Heart Fail 2009;11:958-966.
96. Levine Y, Mittleman MA, Rosenberg M, Buxton A. N-terminal pro-B-type natruiuretic peptide is a major predictor of appropriate ICD therapy. Heart Rhythm 2013;10:A240.
97. Blangy H, Sadoul N, Dousset B, Radauceanu A, Fay R, Aloit E, Zannad F. Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction. Europace 2007;9:724-729.
98. Bezzina CR, Barc J, Mizusawa Y, Remme CA, Gourraud JB, Simonet F, Verkerk AO, Schwartz PJ, Crotti L, Dagradi F, Guicheney P, Fressart V, Leenhardt A, Antzelevitch C, Bartkowiak S, Schulze-Bahr E, Zumhagen S, Behr ER, Bastiaenen R, Tfelt-Hansen J, Salling Olesen M, Kaab S, Beckmann BM, Weeke P, Watanabe H, Endo N, Minamino T, Horie M, Ohno S, Hasegawa K, Makita N, Nogami A, Shimizu W, Aiba T, Frogue P, Balkau B, Lantieri O, Wiese C, Weber D, Wolswinke R, Coronel R, Boukens BJ, Charpentier E, Chatel S, Despres A, Gros F, Kyndt F, Lecointe S, Lindenbaum P, Portero V, Violleau J, Gessler M, Tan HL, Roden DR, Christoffels VM, Le Marec H, Wilde AA, Probst V, Schott JJ, Dina C, Redon R. Common variants at SCN5A/SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet 2013;45:1044-1049.
99. Schwartz PJ. Sudden cardiac death, founder populations and mushrooms. What is the link with gold mines and modifier genes? Heart Rhythm 2011;8:548-550.
100. Schwartz PJ, Ackerman MJ, George AL Jr, Wilde AM. Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol 2013;62:169-180.
101. Crotti L, Monti MC, Insolia R, Peljto A, Goosen A, Brink PA, Greenberg DA, Schwartz PJ, GeorgeALJr.NOS1APis a genetic modifierof the long-QT syndrome. Circulation 2009;120:1657-1663.
102. Amin AS, Giudicessi JR, Tijsen AJ, Spanjaart AM, Reckman YJ, Klemens CA, Tanck MW, Kapplinger JD, Hofman N, Sinner MF, Müller M, Wijnen WJ, Tan HL, Bezzina CR, Creemers EE, Wilde AAM, Ackerman MJ, Pinto YM. Variants in the 3′ untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner. Eur Heart J 2012;33:714-723.
103. Duchatelet S, Crotti L, Peat R, Denjoy I, Itoh H, Berthet M, Ohno S, Fressart V, Monti MC, Crocamo C, Pedrazzini M, Dagradi F, Vicentini A, Klug D, Brink PA, Goosen A, Swan H, Toivonen L, Lahtinen A, Kontula K, Shimizu W, Horie M, George AL, Trégouët DA, Guicheney P, Schwartz PJ. Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in the long QT syndrome. Circ Cardiovasc Genet 2013;6:354-361.
104. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998;98:2334-2351.
105. Friedlander Y, Siscovick DS, Weinmann S, Austin MA, Psaty BM, Lemaitre RN, Arbogast P, Raghunathan TE, Cobb LA. Family history as a risk factor for primary cardiac arrest. Circulation 1998;97:155-160.
106. Jouven X, Desnos M, Guerot C, Ducimetière P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation 1999;99:1978-1983.
107. Dekker LR, Bezzina CR, Henriques JP, Tanck MW, Koch KT, Alings MW, Arnold AE, de Boer MJ, Gorgels AP, Michels HR, Verkerk A, Verheugt FW, Zijlstra F, Wilde AA. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation 2006;114: 1140-1145.
108. Kaikkonen KS, Kortelainen ML, Linna E, Huikuri HV. Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event. Circulation 2006; 114:1462-1467.
109. Kolder IC, Tanck MW, Bezzina CR. Common genetic variation modulating cardiac ECG parameters and susceptibility to sudden cardiac death. J Mol Cell Cardiol 2012; 52:620-629.
110. Spooner PM, Albert C, Benjamin EJ, Boineau R, Elston RC, George AL Jr, Jouven X, Kuller LH, MacCluer JW, Marban E, Muller JE, Schwartz PJ, Siscovick DS, Tracy RP, Zareba W, Zipes DP. Sudden cardiac death, genes, and arrhythmogenesis. Consideration of new population and mechanistic approaches from a National Heart, Lung, Blood Institute workshop. Part I. Circulation 2001;103:2361-2364, and Part II Circulation 2001;103:2447-2452.
111. Bezzina CR, Pazoki R, Bardai A, Marsman RF, de Jong JS, Blom MT, Scicluna BP, Jukema JW, Bindraban NR, Lichtner P, Pfeufer A, Bishopric NH, Roden DM, Meitinger T, Chugh SS, Myerburg RJ, Jouven X, Kääb S, Dekker LR, Tan HL, Tanck MW, Wilde AA. Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction. Nat Genet 2010;42:688-694.
112. Arking DE, Junttila MJ, Goyette P, Huertas-Vazquez A, Eijgelsheim M, Blom MT, Newton-Cheh C, Reinier K, Teodorescu C, Uy-Evanado A, Carter-Monroe N, Kaikkonen KS, Kortelainen ML, Boucher G, Lagacé C, Moes A, Zhao X, Kolodgie F, Rivadeneira F, Hofman A, Witteman JC, Uitterlinden AG, Marsman RF, Pazoki R, Bardai A, Koster RW, Dehghan A, Hwang SJ, Bhatnagar P, Post W, Hilton G, Prineas RJ, Li M, Köttgen A, Ehret G, Boerwinkle E, Coresh J, Kao WH, Psaty BM, Tomaselli GF, Sotoodehnia N, Siscovick DS, Burke GL, Marbán E, Spooner PM, Cupples LA, Jui J, Gunson K, Kesäniemi YA, Wilde AA, Tardif JC, O'Donnell CJ, Bezzina CR, Virmani R, Stricker BH, Tan HL, Albert CM, Chakravarti A, Rioux JD, Huikuri HV, Chugh SS. Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet 2011;7:e1002158.
113. Arking DE, Reinier K, Post W, Jui J, Hilton G, O'Connor A, Prineas RJ, Boerwinkle E, Psaty BM, Tomaselli GF, Rea T, Sotoodehnia N, Siscovick DS, Burke GL, Marban E, Spooner PM, Chakravarti A, Chugh SS. Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest. PLoS One 2010;5:e9879. doi: 10.1371/journal.pone.0009879.
114. Aouizerat BE, Vittinghoff E, Musone SL, Pawlikowska L, Kwok PY, Olgin JE, Tseng ZH. GWAS for discovery and replication of genetic loci associated with sudden cardiac arrest in patients with coronary artery disease. BMC Cardiovasc Disord 2011;11:29.
115. Cheng A, Dalal D, Butcher B, Norgard S, Zhang Y, Dickfeld T, Eldadah ZA, Ellenbogen KA, Guallar E, Tomaselli GF. Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description. J Am Heart Assoc 2013;2:e000083. doi: 10.1161/JAHA.112.000083.
116. Murray SS, Smith EN, Villarasa N, Nahey T, Lande J, Goldberg H, Shaw M, Rosenthal L, Ramza B, Alaeddini J, Han X, Damani S, Soykan O, Kowal RC, Topol EJ, on behalf of the GAME Investigators. Genome-wide association of implantable cardioverter-defibrillator activation with life-threatening arrhythmias. PLoS One 2012;7:e25387. doi: 10.1371/journal.pone.0025387.
117. Wieneke H, Spencker S, Svendsen JH, Martinez JG, Strohmer B, Toivonen L, Le Marec H, Garcia J, Kaup B, Soykan O, Corrado D, Siffert W. Polymorphisms associated with ventricular tachyarrhythmias: rationale, design, and endpoints of the 'diagnostic data influence on disease management and relation of genomics to ventricular tachyarrhythmias in implantable cardioverter/defibrillator patients (DISCOVERY)' study. Europace 2010;12:424-429.
118. Noseworthy PA, Havulinna AS, Porthan K, Lahtinen AM, Jula A, Karhunen PJ,
119. Crotti L, Schwartz PJ. Drug-induced long QT syndrome and exome sequencing: Chinese shadows link past and future. J Am Coll Cardiol 2014;63:1438-1440.
120. Myerburg RJ, Reddy V, Castellanos A. Indications for implantable cardioverterdefibrillators based on evidence and judgment. J Am Coll Cardiol 2009;54:747-763.
121. Wellens HJJ, Gorgels AP, deMunter H. Cardiac arrest outside of a hospital: howcan we improve results of resuscitation?. Circulation 2003;107:1948-1950.